Bionime (TPE:4737) FFO


TPE:4737 Bionime Corp TPE:4737
65 GF Score
Price NT$57.00
GF Value NT$58.96
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bionime FFO?

FFO (Funds from operations) only applies to REITs.

TPE:4737
65GF Score
Bionime Corp TPE:4737
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bionime (TPE:4737) Overvalued in 2026?

Based on GuruFocus' analysis, Bionime stock appears to be undervalued. The current stock price of NT$57.00 is trading 3.3% below its estimated GF Value™ of NT$58.96. GuruFocus considers Bionime to be Fairly Valued.

Key valuation signals for TPE:4737:

  • FFO:
  • GF Value™: NT$58.96 vs. price of NT$57.00 (3.3% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the TPE:4737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bionime Business Description

Address No. 100, Daqing Street, Section 2, South District, Taichung, TWN, 40242
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's revenue is derived from the sale of blood glucose meters and test strips to domestic and foreign clients. Geographically, it operates in Algeria, China, Switzerland, the United States, Belarus, Egypt, the United Arab Emirates, and other countries, of which it derives the maximum revenue from Algeria.
65GF Score

Get the complete analysis for TPE:4737

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$57.00
Price
NT$58.96
GF Value